Variable Gene Copy Number in Cancer-Related Pathways Is Associated With Cancer Prevalence Across Mammals
Molecular Biology and Evolution · 2025
DOI: 10.1093/molbev/msaf056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology and Evolution, 2025. Verfasst von Sophie Matthews und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical and Statistical Science, University of Galway, Galway, Ireland. Hauptthemen laut MEDLINE: Mammals, Neoplasms, DNA Copy Number Variations, Gene Dosage. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cancer is a disease of multicellularity, observed across the tree of life. In principle, animals with larger body sizes and longer lifespans should be at increased risk of developing cancer. However, there is no strong relationship between these traits and cancer across mammals. Previous studies have proposed that increased copy number of cancer-related genes may enhance the robustness of cancer suppression pathways in long-lived mammals, but these studies have not extended beyond known cancer-related genes. In this study, we conducted a phylogenetic generalized least squares analysis to test for associations between copy number of all protein-coding genes and longevity, body size, and cancer prevalence across 94 species of mammals. In addition to investigating the copy number of individual genes, we tested sets of related genes for a relationship between the aggregated gene copy number of the set and these traits. We did not find strong evidence to support the hypothesis that adaptive changes in gene copy number contribute to the lack of correlation between cancer prevalence and body size or lifespan. However, we found several biological processes where aggregate copy number was associated with malignancy rate. The strongest association was for the gene set relating to transforming growth factor beta, a cytokine that plays a role in cancer progression. Overall, this study provides a comprehensive evaluation of the role of gene copy number in adaptation to body size and lifespan and sheds light on the contribution of gene copy number to variation in cancer prevalence across mammals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Mathematical and Statistical Science, University of Galway, Galway, Ireland.
- The SFI Centre for Research Training in Genomics Data Science, University of Galway, Galway, Ireland.
- School of Informatics, Computing and Cyber Systems, Northern Arizona University, Flagstaff, AZ, USA.
- Arizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.
ORCID-Profile: Sophie Matthews, Vahid Nikoonejad Fard, Marc Tollis, Cathal Seoighe
Förderung
- NCI NIH HHS
Zitieren
APA
Matthews, S., Nikoonejad Fard, V., Tollis, M., & Seoighe, C. (2025). Variable Gene Copy Number in Cancer-Related Pathways Is Associated With Cancer Prevalence Across Mammals. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msaf056
Vancouver
Matthews S, Nikoonejad Fard V, Tollis M, Seoighe C. Variable Gene Copy Number in Cancer-Related Pathways Is Associated With Cancer Prevalence Across Mammals. Molecular Biology and Evolution. 2025. doi:10.1093/molbev/msaf056
BibTeX
@article{Matthews2025,
author = {Matthews, Sophie and Nikoonejad Fard, Vahid and Tollis, Marc and Seoighe, Cathal},
title = {Variable Gene Copy Number in Cancer-Related Pathways Is Associated With Cancer Prevalence Across Mammals},
journal = {Molecular Biology and Evolution},
year = {2025},
doi = {10.1093/molbev/msaf056}
}
EUVIMED